Clinical Trial Update: Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating augmented Hyper-CVAD for salvage therapy in acute lymphoblastic leukemia completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-08-23